Regenesis Biomedical

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Regenesis Biomedical sits in the top decile of US sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count).

10 total trials none currently recruiting 8 completed top decile by trial count

Regenesis Biomedical: 10 sponsored US clinical trials, none currently recruiting.

Regenesis Biomedical sponsors 10 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 8 completed. The most-studied condition in this pipeline is Lumbar Surgery, with 1 trials.

Top-decile sponsor footprint

Regenesis Biomedical ranks in the top decile of sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 39/100

8 of 10 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (80.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

10 total, page 1 of 1

COMPLETED NA

Dual Field PEMF Therapy in Lower Extremity Painful Diabetic Distal Symmetric Peripheral Neuropathy

NCT03455543
COMPLETED NA

Study of PEMF to Evaluate VPT and Thermal Sensory in Subjects With Diabetic Peripheral Neuropathy

NCT03077893
COMPLETED NA

A Study to Evaluate PEMF Therapy on Experimentally Inducted Pain in Subjects With Painful Peripheral Diabetic Neuropathy

NCT02809911
COMPLETED NA

A Registry Study to Evaluate Outcomes of PEMF Therapy in Subjects With Various Pain Etiologies

NCT02881112
COMPLETED NA

Proof of Concept Study of PEMF (Pulsed Electromagnetic Field) Therapy in Subjects With Osteoarthritis of the Knee

NCT02696083
COMPLETED NA

Nociceptive Pain Fiber Response

NCT02696070
COMPLETED NA

Study of PEMF (Pulsed Electromagnetic Field) Therapy in the Treatment of Persistent Post-Operative Pain Following Lumbar Surgery

NCT02416973
COMPLETED NA

Pilot Study of PEMF Therapy in Treatment of Post-operative Pain Following Total Knee Arthroplasty

NCT02211534
TERMINATED NA

Pulsed Radiofrequency Energy to Treat Post-Bunionectomy Pain

NCT01694199
TERMINATED NA

A Pilot Study of the Provant Therapy System in Subjects With Diabetic Foot Ulcers

NCT00761176

Therapeutic Areas

Lumbar Surgery 1
Post-Operative Pain Following Total Knee Arthroplasty 1
Diabetic Peripheral Neuropathy 1

How the Regenesis Biomedical archive is shaped

10 indexed studies, none listed as recruiting (0% open); 8 completed (80%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Lumbar Surgery (1 trial), 2 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Regenesis Biomedical: archived-pipeline peers nationwide

Peers matched on 10 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Regenesis Biomedical sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%10%20%30%40% Total trials Recruiting share Regenesis BiomedicalAdamas PharmaceuticalsAdverum BiotechnologiesAevi Genomic Medicine, LLC, a Cerecor companyAgouron Pharmaceuticals10xBio22nd Century Group23andMe3-C Institute for Social Development
Regenesis Biomedical sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Regenesis Biomedical sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 10 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Regenesis Biomedical page

10 registered trials is a research-attention snapshot, not an endorsement of Regenesis Biomedical or any single study.

  • None of Regenesis Biomedical's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Lumbar Surgery is the condition Regenesis Biomedical studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Lumbar Surgery trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Regenesis Biomedical pipeline card: 10 registered trials from official public datasets.Report a data error.